Your browser doesn't support javascript.
loading
A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.
Eder, Ann-Christin; Matthias, Jessica; Schäfer, Martin; Schmidt, Jana; Steinacker, Nils; Bauder-Wüst, Ulrike; Domogalla, Lisa-Charlotte; Roscher, Mareike; Haberkorn, Uwe; Eder, Matthias; Kopka, Klaus.
Affiliation
  • Eder AC; Department of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Matthias J; Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Schäfer M; Department of Radiopharmaceutical Development, German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany and German Cancer Research Center, 69120 Heidelberg, Germany.
  • Schmidt J; Department of Optical Nanoscopy, Max Planck Institute for Medical Research, 69120 Heidelberg, Germany.
  • Steinacker N; Department of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Bauder-Wüst U; Department of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Domogalla LC; Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Roscher M; Department of Radiopharmaceutical Development, German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany and German Cancer Research Center, 69120 Heidelberg, Germany.
  • Haberkorn U; Department of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Eder M; Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Kopka K; Department of Radiopharmaceutical Development, German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany and German Cancer Research Center, 69120 Heidelberg, Germany.
Pharmaceuticals (Basel) ; 15(3)2022 Feb 22.
Article in En | MEDLINE | ID: mdl-35337061

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Journal: Pharmaceuticals (Basel) Year: 2022 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Journal: Pharmaceuticals (Basel) Year: 2022 Type: Article Affiliation country: Germany